Wang, F. et al. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA 112, 4743–4748 (2015).
Fauser, B. C. J. M. et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum. Reprod. 19, 41–47 (2004).
Azziz, R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil. Steril. https://doi.org/10.1016/j.fertnstert.2005.01.085 (2005).
Azziz, R. et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456–488 (2009).
Yedulapuram, S. H., Gunda, M., Moola, N. R. & Kadarla, R. K. An overview on polycystic ovarian syndrome. Asian J. Pharm. Res. Dev. 7, 72–80 (1970).
Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J. & Moran, L. J. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin. Endocrinol. 89, 683–699 (2018).
Kazemi, M. et al. Comprehensive evaluation of type 2 diabetes and cardiovascular disease risk profiles in reproductive-age women with polycystic ovary syndrome: a large canadian cohort. J. Obstet. Gynaecol. Canada 41, 1453–1460 (2019).
Kakoly, N. S., Moran, L. J., Teede, H. J. & Joham, A. E. Cardiometabolic risks in PCOS: a review of the current state of knowledge. Exp. Rev. Endocrinol. Metab. 14, 23–33 (2019).
Dokras, A., Clifton, S., Futterweit, W. & Wild, R. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: Systematic review and meta-analysis. Fertil. Steril. 97, 225-230.e2 (2012).
Chen, S. F., Yang, Y. C., Hsu, C. Y. & Shen, Y. C. Risk of bipolar disorder in patients with polycystic ovary syndrome: a nationwide population-based cohort study. J. Affect. Disord. 263, 458–462 (2020).
Thannickal, A. et al. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Clin. Endocrinol. (Oxf) 92, 338–349 (2020).
Barthelmess, E. K. & Naz, R. K. Polycystic ovary syndrome: current status and future perspective. Frontiers Biosci. Elite 6E, 104–119 (2014).
Joseph, S., Barai, R. S., Bhujbalrao, R. & Idicula-Thomas, S. PCOSKB: A knowledgebase on genes, diseases, ontology terms and biochemical pathways associated with polycystic ovary syndrome. Nucleic Acids Res. https://doi.org/10.1093/nar/gkv1146 (2016).
Afiqah-Aleng, N., Harun, S., A-Rahman, M. R. A., Nor Muhammad, N. A. & Mohamed-Hussein, Z. A. PCOSBase: a manually curated database of polycystic ovarian syndrome. Database https://doi.org/10.1093/database/bax098 (2017).
Maniraja, J. M., Vetrivel, U., Munuswamy, D. & Melanathuru, V. PCOSDB: PolyCystic ovary syndrome DataBase for manually curated genes associated with the disease. Bioinformation 12, 4–8 (2016).
Bardou, P., Mariette, J., Escudié, F., Djemiel, C. & Klopp, C. Jvenn: an interactive Venn diagram viewer. BMC Bioinform. 15, 293 (2014).
Scicchitano, P. et al. Cardiovascular risk in women with PCOS. Int. J. Endocrinol. Metab. 10, 611–618 (2012).
Kulshreshtha, B., Singh, S. & Arora, A. Family background of Diabetes Mellitus, obesity and hypertension affects the phenotype and first symptom of patients with PCOS. Gynecol. Endocrinol. 29, 1040–1044 (2013).
Sirmans, S. M., Parish, R. C., Blake, S. & Wang, X. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J. Investig. Med. 62, 868–874 (2014).
Elting, M. W., Korsen, T. J., Bezemer, P. D. & Schoemaker, J. Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum. Reprod. 16, 556–560 (2001).
Rasgon, N. L. et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J. Affect. Disord. 74, 299–304 (2003).
Rodriguez-Paris, D. et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr. Pol. 53, 955–966 (2019).
Rassi, A. et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr. Psychiatry 51, 599–602 (2010).
Hung, J. H. et al. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One 9, e97041 (2014).
Annagür, B. B., Kerimoglu, ÖS., Tazegül, A., Gündüz, Ş & Gençoglu, B. B. Psychiatric comorbidity in women with polycystic ovary syndrome. J. Obstet. Gynaecol. Res. 41, 1229–1233 (2015).
Brutocao, C. et al. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 62, 318–325 (2018).
Cheung, B. M. Y. The hypertension-diabetes continuum. J. Cardiovasc. Pharmacol. 55, 333–339 (2010).
Zhao, L. et al. Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Endocr. Disord. 18, 65 (2018).
Jiao, X. et al. Variant alleles of the ESR1, PPARG, HMGA2, and MTHFR genes are associated with polycystic ovary syndrome risk in a Chinese population: A case-control study. Front. Endocrinol. (Lausanne) 9, 504 (2018).
Jakimiuk, A. J., Weitsman, S. R., Yen, H. W., Bogusiewicz, M. & Magoffin, D. A. Estrogen receptor α and β expression in theca and granulosa cells from women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 5532–5538 (2002).
Wong, W. T., Tian, X. Y. & Huang, Y. Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent COX-2-derived prostanoids. J. Cardiovasc. Pharmacol. 61, 204–214 (2013).
Schmidt, J. et al. Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women. Mol. Hum. Reprod. 20, 49–58 (2014).
Supriya, R. et al. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults. PLoS One 13, e0201585 (2018).
Gacka, M. & Adamiec, R. Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications. Postepy Hig. Med. Dosw. (Online) 58, 483–489 (2004).
Tsatsakis, A. M., Zafiropoulos, A., Tzatzarakis, M. N., Tzanakakis, G. N. & Kafatos, A. Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides. Toxicol. Lett. 186, 66–72 (2009).
Wang, Y. et al. Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in south-west Chinese women. Eur. J. Endocrinol. 166, 877–885 (2012).
Ohashi, K., Ouchi, N. & Matsuzawa, Y. Adiponectin and Hypertension. Am. J. Hypertens. 24, 263–269 (2011).
Davis, S. K. et al. Association of adiponectin with type 2 diabetes and hypertension in African American men and women: The Jackson Heart Study. BMC Cardiovasc. Disord. 15, 13 (2015).
Mirza, S. S., Shafique, K., Shaikh, A. R., Khan, N. A. & Anwar Qureshi, M. Association between circulating adiponectin levels and polycystic ovarian syndrome. J. Ovarian Res. 7, 18 (2014).
Cooney, L. G. & Dokras, A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Current Psychiatry Rep. 19, 83 (2017).
Meczekalski, B., Pérez-Roncero, G. R., López-Baena, M. T., Chedraui, P. & Pérez-López, F. R. The polycystic ovary syndrome and gynecological cancer risk. Gynecol. Endocrinol. 36, 289–293 (2020).
Feng, Y. et al. Effects of androgen and leptin on behavioral and cellular responses in female rats. Horm. Behav. 60, 427–438 (2011).
Kamalanathan, S., Sahoo, J. & Sathyapalan, T. Pregnancy in polycystic ovary syndrome. Indian J. Endocrinol. Metab. 17, 37 (2013).
Hartanti, M. D. et al. Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?. PLoS One 15, e0229351 (2020).
Scalici, E. et al. Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process. Sci. Rep. 6, 1–10 (2016).
He, T. et al. MicroRNA-141 and MicroRNA-200c are overexpressed in granulosa cells of polycystic ovary syndrome patients. Front. Med. 5, 299 (2018).
Tesfaye, D. et al. Potential role of microRNAs in mammalian female fertility. Reprod. Fertil. Dev. 29, 8–23 (2017).
Lykoudi, A. et al. Dysregulated placental microRNAs in early and Late onset Preeclampsia. Placenta 61, 24–32 (2018).
Lu, J., Wang, Z., Cao, J., Chen, Y. & Dong, Y. A novel and compact review on the role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 16, 80 (2018).
Lundberg, F. E., Iliadou, A. N., Rodriguez-Wallberg, K., Gemzell-Danielsson, K. & Johansson, A. L. V. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur. J. Epidemiol. 34, 499–507 (2019).
Yin, W., Falconer, H., Yin, L., Xu, L. & Ye, W. Association between polycystic ovary syndrome and cancer risk. JAMA Oncol. 5, 106–107 (2019).
Wolf, W. M., Wattick, R. A., Kinkade, O. N. & Olfert, M. D. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int. J. Environ. Res. Public Health 15, 2589 (2018).
Khan, M. J., Ullah, A. & Basit, S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl. Clin. Genet. 12, 249–260 (2019).
Choudhary, A., Jain, S. & Chaudhari, P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?. Int. J. Reprod. Contracept. Obstet. Gynecol. 6, 4971 (2017).
Belenkaia, L. V., Lazareva, L. M., Walker, W., Lizneva, D. V. & Suturina, L. V. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecol. 71, 211–225 (2019).
Nouraldein, M., Hamad, M., Abdelgadir, M. A., Omer, M. & Hussein, M. Prevalence of Stein-Leventhal syndrome. EC EC Gynaecol. 9, 52–55 (2020).
Canese, K. & Weis, S. PubMed: The bibliographic database. NCBI Handb. (2013)
Lipscomb, C. E. Medical Subject headings (MeSH). Bull. Med. Libr. Assoc. 88, 265–266 (2000).
Brown, G. R. et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 43, D36-42 (2015).
Sherry, S. T. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. https://doi.org/10.1093/nar/29.1.308 (2001).
Zerbino, D. R. et al. Ensembl 2018. Nucleic Acids Res. https://doi.org/10.1093/nar/gkx1098 (2018).
Bateman, A. et al. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204–D212 (2015).
Rose, P. W. et al. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. https://doi.org/10.1093/nar/gkw1000 (2017).
Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 43, D1049–D1056 (2015).
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109–D114 (2012).
Hamosh, A., Scott, A. F., Amberger, J., Valle, D. & McKusick, V. A. Online mendelian inheritance in man (OMIM). Hum. Mutat. 15, 57–61 (2000).
Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. https://doi.org/10.1093/nar/gkx1132 (2018).
Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. https://doi.org/10.1093/nar/gky1131 (2019).
Piñero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. https://doi.org/10.1093/nar/gkz1021 (2020).
NIH, N. MedGen. NIH (2016).
Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. https://doi.org/10.1093/nar/gkt1113 (2014).
Davis, A. P. et al. The comparative toxicogenomics database: update 2019. Nucleic Acids Res. 47, D948–D954 (2019).
England, G. The 100,000 genomes project protocol v3 genomics England. Genomics Engl. Protoc. https://doi.org/10.6084/m9.figshare.4530893.v2 (2017).
Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. https://doi.org/10.1093/nar/gkt1229 (2014).
Flint, J. GWAS. Curr. Biol. https://doi.org/10.1016/j.cub.2013.01.040 (2013).
Bravo, À, Piñero, J., Queralt-Rosinach, N., Rautschka, M. & Furlong, L. I. Extraction of relations between genes and diseases from text and large-scale data analysis: Implications for translational research. BMC Bioinform. 16, 55 (2015).
Bundschus, M., Dejori, M., Stetter, M., Tresp, V. & Kriegel, H. P. Extraction of semantic biomedical relations from text using conditional random fields. BMC Bioinform. 9, 207 (2008).
Rani, J., Shah, A. R. & Ramachandran, S. pubmed.mineR: An R package with text-mining algorithms to analyse PubMed abstracts. J. Biosci. 40, 671–682 (2015).
The Lancet. ICD-11. The Lancet (Elesiver, Asterdam, 2019). https://doi.org/10.1016/S0140-6736(19)31205-X.
Heat Map Chart|Basic Charts|AnyChart Documentation. Available at: https://docs.anychart.com/Basic_Charts/Heat_Map_Chart. (Accessed: 5th May 2020)
Rubio-Perez, C. et al. Genetic and functional characterization of disease associations explains comorbidity. Sci. Rep. 7, 1–14 (2017).
Carson, M. B., Liu, C., Lu, Y., Jia, C. & Lu, H. A disease similarity matrix based on the uniqueness of shared genes. BMC Med. Genom. 10, 26 (2017).
Sun, K., Gonçalves, J. P., Larminie, C. & Pržulj, N. Predicting disease associations via biological network analysis. BMC Bioinform. 15, 304 (2014).
Menche, J. et al. Uncovering disease-disease relationships through the incomplete interactome. Science 347(80), 347–841 (2015).
vis.js. Available at: https://visjs.org/. (Accessed: 9th May 2020)
Goh, K. . Il. et al. The human disease network. Proc. Natl. Acad. Sci. USA 104, 8685–8690 (2007).
miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database – PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/31647101/. (Accessed: 4th August 2020)
Csardi, G. & Nepusz, T. The igraph software package for complex network research. InterJ. Complex Syst. 1695(5), 1–9 (2006).
Rakshit, H., Rathi, N. & Roy, D. Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson’s Disease. PLoS ONE 9, e103047 (2014).